Table 1 The clinical characteristics of diabetes cohort from Beijing
From: Large-scale in silico identification of drugs exerting sex-specific effects in the heart
| Â | Men | Women | P values |
|---|---|---|---|
N | 9 | 26 | Â |
Age | 55.11 ± 6.51 | 55.15 ± 6.27 | 0.9865 |
SBP (mmHg) | 139.41 ± 14.30 | 131.05 ± 13.95 | 0.1447 |
DBP (mmHg) | 89.11 ± 8.69 | 77.19 ± 8.21 | 0.0011 |
HR (bmp) | 75 ± 12 | 75 ± 9 | 0.9920 |
BMI (kg/m2) | 24.63 ± 2.58 | 28.20 ± 3.56 | 0.0112 |
Glu (mM) | 4.95 ± 0.58 | 5.23 ± 0.44 | 0.1487 |
TG (mM) | 1.46 ± 1.16 | 1.92 ± 0.82 | 0.2187 |
TC (mM) | 4.87 ± 0.38 | 5.03 ± .81 | 0.5711 |
HDL-c (mM) | 1.35 ± 0.38 | 1.24 ± 0.23 | 0.2967 |
LDL-c (mM) | 2.92 ± 0.31 | 3.11 ± 0.71 | 0.4584 |
Other medication | ACEI (0) | ACEI (0) | Â |
ARB (0) | ARB (2) | Â | |
CCB (1) | CCB (4) | Â | |
Diuretics (1) | Diuretics (1) | Â | |
Co-morbidities | Diabetes (9) | Diabetes (26) | Â |
CHD (1) | CHD (1) | Â |